Stock ATNM ACTINIUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Actinium Pharmaceuticals, Inc.

Equities

ATNM

US00507W2061

Real-time Estimate Cboe BZX
Other stock markets
 03:45:06 2024-05-02 pm EDT 		5-day change 1st Jan Change
8.77 USD +12.72% Intraday chart for Actinium Pharmaceuticals, Inc. +33.54% +72.44%
Apr. 26 Actinium Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Actinium Pharmaceuticals, Inc. Highlights Ability of Iomab-B to Overcome High-Risk TP53 Mutation Resulting in Significant Improvement in Overall Survival in Patients with Active Relapsed Refractory AML at the European Bone Marrow Transplant Annual Meeting CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ACTINIUM PHARMACEUTICALS, INC.
Bio Therapeutic Drugs
+12.72%+33.54%+72.44%-2.99%-2.34% 232M
Bearish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. ATNM Stock
  4. Charts Actinium Pharmaceuticals, Inc.
  5. Relative Strength Chart